Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The cbl oncogene: a novel substrate of protein tyrosine kinases.

Australian and New Zealand journal of medicine - 1 Dec 1995

Langdon W Y

Abstract excerpt

The cbl oncogene was first identified as part of a transforming retrovirus which arose in a mouse pre-B cell lymphoma. Its protein product, p120cbl, is cytoplasmic and has several distinctive domains including a highly basic region, a RING finger motif and a large proline-rich domain. A mutation to cbl in the 70Z/3 pre-B cell lymphoma produces an oncogenic protein which exhibits a marked enhancement of tyrosine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mice
Share to Cell Line
Share to Cell Transformation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Models, Genetic

Share to Mutation

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins

Share to Signal Transduction

Source

Identifiers

PMID: 8770364
DOI: 10.1111/j.1445-5994.1995.tb02892.x

Genes

EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cbl oncogene: a novel substrate of protein tyrosine kinases.PMID 8770364Read ↗

The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase.Semantic proximity Read ↗

Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.Semantic proximity Read ↗

EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.Semantic proximity Read ↗

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disordersSemantic proximity Read ↗

CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.Semantic proximity Read ↗

Role of CBL Mutations in Cancer and Non-Malignant PhenotypeSemantic proximity Read ↗

Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.Semantic proximity Read ↗

CBL mutations promote activation of PI3K/AKT signaling via LYN kinaseSemantic proximity Read ↗

The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategiesSemantic proximity Read ↗

Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.Semantic proximity Read ↗

Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of AgeSemantic proximity Read ↗

The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.